Find out how Oxford’s AI tool HyPrevent could identify hidden organ damage from high blood pressure and support a more ...
Introduction Efficient preventive management of acute exacerbation of chronic obstructive pulmonary disease (COPD) is ...
A new algorithm could drive breakthroughs in understanding cancer, Alzheimer's disease and other potentially fatal conditions ...
Abstract: Heart disease remains a leading cause of mortality worldwide, necessitating early and accurate detection to improve patient outcomes. This paper presents a Heart Disease Prediction System ...
Abstract: This Study will explore how the IoT and machine learning predict heart disease risks through real-time wearable device and sensor data. The Cleveland and Hungarian datasets have relevant ...
Heart disease is on track to tighten its grip on American women. New projections from the American Heart Association warn that over the next 25 years, cardiovascular disease will rise sharply, driven ...
A single infusion of an experimental gene-editing drug seemed to reduce LDL long-term in a small trial. The results may point to something “curative,” one expert said. By Gina Kolata In a small, ...
Millions of people are diagnosed with Alzheimer’s disease each year, comprising 60% to 70% of dementia cases worldwide. While cognitive impairment and structural brain changes are indicative of ...
Haley Billey bought an Oura Ring to track her fertility. It arrived the day after she learned she was pregnant. She slipped the $450 titanium band on anyway. Months of worrisome readings on measures ...
A tool developed by the American Heart Association (AHA), proven to accurately predict heart disease risk for Americans, can be applied to the global population, a new study led by NYU Langone Health ...
Researchers at the University of Glasgow have developed a new way to test networks, which they claim is 25,000 times faster than traditional approaches. Shenjia Ding, a research student at the ...
A study by investigators at Mass General Brigham has found that a blood test of plasma phosphorylated tau 217 (pTau217), an Alzheimer's disease biomarker, can predict the progression of amyloid PET ...